STARD10 regulates human pancreatic β cell differentiation and triglyceride metabolism

Read full text
Authors: Wei Xuan Tan, Nur Shabrina Amirruddin, Euodia Xi Hui Lim, Ming Hu, Sneha Muralidharan, Peter Imre Benke, Federico Tesio Torta, Shawn S. Hoon, Andreas Alvin Purnomo Soetedjo, Hwee Hui Lau, Natasha H.J. Ng, Guy A. Rutter
+1 more Adrian Kee Keong Teo
Cited by: 0
References: 37

Abstract

The STARD10 gene encodes for a lipid transfer protein and is associated with type 2 diabetes (T2D) risk and β cell function. However, the role of STARD10 in human β cell development and function are still unclear. Here, we deleted STARD10 in human embryonic stem cells and differentiated them into β-like cells. The deletion of STARD10 reduced the formation of INS + β-like cells and proliferation. Lipidomics analyses revealed that STARD10 -null β-like cells had higher triglyceride levels. Consistently, the expression levels of ETFB, which is involved in fatty acid β-oxidation, were severely reduced in STARD10 -null β-like cells. STARD10 -null β-like cells also had reduced glycolytic function, mitochondrial oxidative phosphorylation, and palmitate oxidation, which can likely contribute to slower proliferation and β cell dysfunction. Overall, our findings provided further insights into the role of STARD10 in human β cell development and function, and how its loss-of-function can contribute to increased T2D risk.

Fields of Study & Subjects

Pancreatic function and diabetes Diabetes and associated disorders Pluripotent Stem Cells Research

Publication details

Journal / source
Stem Cell Reports
Volume
21
Issue
3
Pages
102815–102815
Publication date
12 February 2026
Language
EN